These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 37506990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX, Wei M, Xiang R, Lu YM, Zhang L, Li YD, Zhang JH, Xing Q, Tu-Erhong ZK, Tang BP, Zhou XH.
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1741-1755. PubMed ID: 34389210
    [Abstract] [Full Text] [Related]

  • 3. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT.
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
    [Abstract] [Full Text] [Related]

  • 4. Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta-analysis.
    Tatum R, Maynes EJ, Wood CT, Deb AK, Austin MA, O'Malley TJ, Choi JH, Massey HT, Morris RJ, Pavri BB, Tchantchaleishvili V.
    Pacing Clin Electrophysiol; 2021 Aug; 44(8):1297-1302. PubMed ID: 34081789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P, Özer N, Ateş AH, Yorgun H, Oto A, Aytemir K.
    Cardiol J; 2015 Aug; 22(6):637-44. PubMed ID: 26412607
    [Abstract] [Full Text] [Related]

  • 9. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [Abstract] [Full Text] [Related]

  • 10. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads.
    Kucukarslan N, Kirilmaz A, Ulusoy E, Yokusoglu M, Gramatnikovski N, Ozal E, Tatar H.
    J Card Surg; 2006 Jun; 21(4):391-4. PubMed ID: 16846419
    [Abstract] [Full Text] [Related]

  • 11. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL.
    J Am Coll Cardiol; 2005 May 17; 45(10):1672-5. PubMed ID: 15893186
    [Abstract] [Full Text] [Related]

  • 12. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G, Levi T, Perelshtein Brezinov O, Valdman A, Rahkovich M, Kogan Y, Laish-Farkash A.
    Isr Med Assoc J; 2022 Jan 17; 24(1):25-32. PubMed ID: 35077042
    [Abstract] [Full Text] [Related]

  • 13. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW, Pislaru SV, Lin G, Powell BD, Espinosa R, Koestler C, Thome T, Polk L, Li Z, Asirvatham SJ, Cha YM.
    Heart Rhythm; 2018 Jul 17; 15(7):1009-1016. PubMed ID: 29496605
    [Abstract] [Full Text] [Related]

  • 14. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 38812433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study.
    Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR.
    J Am Soc Echocardiogr; 2008 Mar 02; 21(3):284-7. PubMed ID: 17604958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-Term Follow-Up of Mortality and Heart Failure Hospitalisation in Patients With Intracardiac Device-Related Tricuspid Regurgitation.
    Kanawati J, Ng ACC, Khan H, Yu C, Hyun K, Abed H, Kritharides L, Sy RW.
    Heart Lung Circ; 2021 May 02; 30(5):692-697. PubMed ID: 33132050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.